Your browser doesn't support javascript.
loading
Anticancer effect of verteporfin on non-small cell lung cancer via downregulation of ANO1.
Jeong, Sung Baek; Das, Raju; Kim, Dong-Hyun; Lee, Sion; Oh, Hye In; Jo, Sungwoo; Lee, Yechan; Kim, Jeongdong; Park, SeonJu; Choi, Dong Kyu; Moon, Uk Yeol; Kwon, Oh-Bin; Namkung, Wan; Lee, Sungwoo; Cho, Byoung Chul; Woo, Joohan; Seo, Yohan.
Afiliación
  • Jeong SB; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: sjeong100@kmedihub.re.kr.
  • Das R; Department of Physiology, Dongguk University College of Medicine, Gyeongju, the Republic of Korea. Electronic address: rajudasbgc@gmail.com.
  • Kim DH; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: kdh1007@kmedihub.re.kr.
  • Lee S; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: sionlee@kmedihub.re.kr.
  • Oh HI; Underwood Division Economics, Underwood International College, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, the Republic of Korea. Electronic address: arielleohhyein@yonsei.ac.kr.
  • Jo S; College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, the Republic of Korea. Electronic address: dsdyu2005@naver.com.
  • Lee Y; College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, the Republic of Korea. Electronic address: llyycc94@naver.com.
  • Kim J; College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, the Republic of Korea. Electronic address: tonightsky@naver.com.
  • Park S; Chuncheon Center, Korea Basic Science Institute (KBSI), Chuncheon 24341, the Republic of Korea. Electronic address: sjp19@kbsi.re.kr.
  • Choi DK; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: dongkyu@kmedihub.re.kr.
  • Moon UY; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: bluemuy@kmedihub.re.kr.
  • Kwon OB; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: kob325@kmedihub.re.kr.
  • Namkung W; College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, the Republic of Korea; Interdisciplinary Program of Integrated OMICS for Biomedical Science Graduate School, Yonsei University, Seoul 03722, the Republic of Korea. El
  • Lee S; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: sungwoolee@kmedihub.re.kr.
  • Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, the Republic of Korea. Electronic address: cbc1971@yuhs.ac.
  • Woo J; Department of Physiology, Dongguk University College of Medicine, Gyeongju, the Republic of Korea; Channelopathy Research Center (CRC), Dongguk University College of Medicine, 32 Dongguk-ro, Ilsan Dong-gu, Goyang, Gyeonggi-do 10326, the Republic of Korea. Electronic address: gabriel929@dongguk.ac.kr
  • Seo Y; New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu, the Republic of Korea. Electronic address: yohanseo@kmedihub.re.kr.
Biomed Pharmacother ; 153: 113373, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35785700

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Anoctamina-1 / Verteporfina / Neoplasias Pulmonares / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Anoctamina-1 / Verteporfina / Neoplasias Pulmonares / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article Pais de publicación: Francia